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Purpose: Recent studies suggest a role for distal airway injury in acute respiratory distress syndrome
(ARDS). The epithelium lining the small airways secretes a large number of molecules such as
surfactant components and inflammatory mediators. There is little information on how these small
airway secretory functions are altered in ARDS.
Materials and Methods: We studied the lungs of 31 patients with ARDS (PaO2/fraction of inspired
oxygen ≤200, 45 ± 14 years, 16 men) and 11 controls (52 ± 16 years, 7 men) submitted to autopsy and
quantified the expression of interleukin (IL) 6, IL-8, surfactant proteins (SP) A and SP-B in the epithelium
of small airways using immunohistochemistry and image analysis. In addition, an index of airway
epithelial apoptosis was determined by the terminal deoxynucleotidyl transferase-mediated deoxyuridine-
triphosphatase nick-end labeling assay, caspase 3, and Fas/Fas ligand expression. The density of
inflammatory cells expressing IL-6 and IL-8 within the small airway walls was also quantified.
Results: Acute respiratory distress syndrome airways showed an increase in the epithelial expression
of IL-8 (P = .006) and an increased density of inflammatory cells expressing IL-6 (P = .004) and IL-8
(P b .001) compared with controls. There were no differences in SP-A and SP-B epithelium
expression or in epithelial apoptosis index between ARDS and controls.
Conclusion: Distal airways are involved in ARDS lung inflammation and show a high expression of
proinflammatory interleukins in both airway epithelial and inflammatory cells. Apoptosis may not be
a major mechanism of airway epithelial cell death in ARDS.
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Airway dysfunction has been increasingly recognized as
an important contributor to pulmonary impairment in
patients with acute respiratory distress syndrome (ARDS)
[1]. Acute respiratory distress syndrome is characterized by
the abrupt onset of hypoxemia with diffuse pulmonary
inﬁltrates and an accumulation of a protein-rich pulmonary
edema that causes reduction in lung compliance, alveolar
collapse, and ventilation-perfusion mismatch [2]. Further-
more, increased lung resistance, expiratory ﬂow limitations,
and dynamic hyperinﬂation have also been reported, which
are partially attributed to airway closure [1,3].
Animal models of acute lung injury (ALI) have shown
that, in addition to damage to the parenchyma in ALI/ARDS,
small airway injuries are characterized by bronchiolar
epithelial necrosis and sloughing and by rupture of
alveolar-bronchiolar attachments [4-8]. The loss of mechan-
ical alveolar/airway interdependence, airway epithelial inju-
ry, interstitial edema, and alveolar collapse may all contribute
to distal airway instability [1,7]. We have recently reported
that in humans who died with ARDS, small airway changes
were characterized by wall thickening with inﬂammation,
extracellular matrix remodeling, and epithelial denudation
[9]. Importantly, the degree of airway epithelial denudation in
these patients was associated with disease severity.
Previous studies have suggested a role for distal airway
epithelium injury in the pathophysiology of human ALI/
ARDS [10,11]. The epithelium lining the airways modulates
airway function by secreting a large number of molecules
such as surfactant components and inﬂammatory mediators
[12]. Changes in the composition and function of the
surfactants released by the airways are observed in different
pulmonary diseases, such as asthma and chronic bronchitis.
Dysfunction of airway surfactants can be associated with the
impairment of host defenses and distal airway stability [13].
So far, there is little information on how these secretory
functions of the small airways are altered in ARDS. Among
the inﬂammatory mediators involved in lung injury in
ARDS, interleukins (IL) 6 and IL-8 were increased in both
serum and bronchoalveolar lavage (BAL) [14,15], and the
serum interleukins levels were associated with increased
mortality and morbidity [14]. The expression of these
interleukins in airway epithelial cells has not been addressed
in ARDS.
Alveolar cell apoptosis is increased in patients with ARDS
and is likely to contribute to alveolar injury; the Fas/Fas
ligand (FasL) system, a surface receptor and its natural ligand,
seems to play a central role in this process [16]. We have
previously reported that bronchiolar epithelium injury and
denudation are present in humans with ARDS and are
associated with disease severity [9]; the mechanism of airway
cell injury in these patients is not known. We hypothesized
that apoptosis could be an important mechanism of epithelial
cell death not only in the alveolar epithelium but also in the
distal airways in ARDS.In this study, we assessed small airway alterations that
could be involved in pulmonary inﬂammation and surfactant
dysfunction in ARDS. For this purpose, we measured airway
expression of the inﬂammatory cytokines IL-6 and IL-8, the
airway expression of the surfactant proteins (SP) A and SP-
B, and an index of airway epithelial apoptosis of patients
with ARDS submitted to autopsy and compared the results
with those of control subjects.2. Methods
This study was approved by the review board for human
studies of the São Paulo University Medical School
(CAPPesq-FMUSP). The study is retrospective and used
archived material from routine autopsies performed at the
Autopsy Service of Sao Paulo University Medical School.
Consent for performing autopsy was obtained from the next
of kin of all the subjects involved in the study.
2.1. Study population
Lung tissue from 31 patients with ARDS submitted to
autopsy at Sao Paulo University Medical School between
2004 and 2007 was retrospectively included in the study.
Inclusion criteria were a clinical diagnosis of ARDS deﬁned
according to the American-European Consensus criteria
[17], histologic ﬁndings of diffuse alveolar damage [18], an
absence of chronic lung diseases, and sufﬁcient archived
autopsy material (at least 3 small airways per patient) for
analysis. Eleven nonsmoker, nonventilated patients who died
of nonpulmonary causes, without previous lung diseases
were used as controls. Control subjects showed normal lungs
at gross and microscopic examination. We have character-
ized this population in a previous study [9].
The following clinical data were obtained from medical
charts: age, sex, predisposing cause of ARDS, cause of
death, days of ARDS evolution (time interval between
ARDS diagnosis and death), partial pressure of oxygen
(PaO2), plateau pressure, positive end-expiratory pressure
(PEEP), and the ratio of PaO2 to fraction of inspired oxygen
(FIO2) assessed at the time of the clinical diagnosis.
2.2. Tissue processing and histologic analysis
Parafﬁn blocks of lung tissue collected during routine
autopsywere retrieved from the archives of the Department of
Pathology of Sao Paulo University Medical School. In the
routine autopsies, 3 to 4 fragments of lung tissue were
collected from any regions of altered lung parenchyma. In
normal lungs, 1 fragment of lung tissue was collected from
each lobe. The tissue had been previously ﬁxed in 10%
buffered formalin for 24 hours, routinely processed and
parafﬁn embedded. Sections 5 μm thick were stained
with hematoxylin and eosin for histologic diagnoses of
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Small airways were deﬁned as those with a diameter of
2.0 mm or less in a transversal section (short/long diameter
ratio N0.6) [19].
The following parameters were analyzed in the small
airways: epithelial expression of SP-A and SP-B, epithelial
apoptosis, and the airway expression of inﬂammatory
cytokines. Apoptosis was assessed with caspase 3 expres-
sion, Fas/FasL epithelial expression and the peroxidase
terminal deoxynucleotidyl transferase-mediated deoxyuri-
dine-triphosphatase nick-end labeling (TUNEL) assay [20].
The airway expression of inﬂammatory cytokines was
assessed as the epithelial expression of IL-6 and IL-8 and
as the density of IL-positive inﬂammatory cells within the
airway wall.
The following proteins were identiﬁed with immunohis-
tochemistry as previously described [19]: SP-A, SP-B, IL-6,
IL-8, caspase 3, Fas, and FasL. Brieﬂy, sections were
deparafﬁnized, and a 0.3% hydrogen peroxide solution was
applied for 35 minutes to inhibit endogenous peroxidase
activity. Antigen retrieval (except for SP-A) was performed
with a citrate solution for 45 minutes. Sections were
incubated with the primary antibody overnight at 4°C (SP-
A, 1:1200, DAKO, Glostrup, Denmark; SP-B, 1:400,
Labvision, Fremont, Calif; IL-6, 1:20, R&D, Minneapolis,
Minn; IL-8, 1:100, R&D; Fas, 1:1200, Santa Cruz Bio-
technologies, Santa Cruz, Calif; FasL, 1:100, Santa Cruz
Biotechnologies; Caspase 3, 1:500, Novocastra, Newcastle,
UK). Novolink Polymer (Novocastra) was used as the
secondary antibody and 3,3’-diaminobenzidine (Sigma
Chemical Co, St Louis, Mo) as the chromogen. The sections
were counterstained with Harris hematoxylin. For negative
controls, the primary antibody was replaced by phosphate-
buffered saline.
Protein epithelial expression was assessed using Image-
Pro Plus 4.1 for Windows image analysis software (Media
Cybernetics, Silver Spring, Md) on a personal computer
connected to a digital camera coupled to a microscope (Leica
DMR, Leica Microsystems Wetzlar GmbH, Wetzlar, Ger-
many). The image analysis system measured the mean color
density of the immunohistochemical staining in the small
airway epithelium, which represents the mean intensity of the
staining within the positive area (range, 0-255) [21]. The
expression of SP-A, SP-B, IL-6, IL-8, Fas, and FasL in the
epithelium was calculated as the product of the area of
positive staining and mean density, normalized by the
corresponding epithelial basement membrane length [22].
This index of protein expression takes into account both the
intensity and the area of staining. The densities of IL-6– and
IL-8–positive cells in the small airway were calculated as the
number of positive cells within the airway wall normalized
by the basal membrane length (cells per micrometer). The
apoptosis index by TUNEL assay and caspase 3 expression
was calculated as the number of epithelial-positive cells
divided by the corresponding basal membrane length (cells
per micrometer).At least 3 small airways were analyzed per patient by
an investigator blinded to the study group. The entire
airway circumference was analyzed for each variable, at a
200× magniﬁcation.
2.3. Clinical correlations
Because lung injury can be observed after a few hours of
injurious mechanical ventilation [4], we investigated the
possible association of airway changes with mechanical
ventilation and disease severity in patients with ARDS who
died within 48 hours after diagnosis (n = 16). For this
purpose, we correlated the histologic parameters with the
ventilatory parameters (mean values of plateau pressure and
PEEP) and the PaO2/FIO2 value obtained at the moment of the
clinical diagnosis.
To evaluate the airway changes over the course of the
disease, we correlated the different histologic parameters
with the time interval between ARDS diagnosis and death
(days of ARDS evolution).
Statistical analysis was performed using the statistical
software SPSS 15.0 (SPSS, Chicago, Ill). According to the
distribution of each variable, either the Student t test or the
Mann-Whitney U test was used to compare data between the
ARDS and control groups. The association between
histologic and clinical data was analyzed by Pearson or
Spearman rank test. Data are presented as mean ± SD or
median (interquartile range). The level of signiﬁcance was
set at P b .05.3. Results
3.1. Study population
Demographic and clinical data of the ARDS (n = 31) and
control (n = 11) groups are presented in Table 1. The main
predisposing factors for ARDS were pneumonia (42%) and
sepsis (35%). Median values of plateau pressure and PEEP in
patients with ARDS were 28 (10) cm H2O and 11 (8) cm
H2O, respectively. Individual values of ventilatory parame-
ters, PaO2/FIO2 values, and days of ARDS evolution were
previously reported [9]. Ventilatory management was based
on a protective low-tidal volume strategy (4-6 mL/kg of
predicted body weight) [23]. None of the subjects in the
control group were mechanically ventilated.
3.2. Image analysis
Adequate samples (lung tissue containing at least 3
small transversely cut airways) were available for 18 to 31
patients with ARDS and 6 to 11 control subjects,
depending on the protein studied. All available small
airways for each patient were analyzed (Table 2). A total
of 1798 distal airways were analyzed (mean of 6 airways
Table 2 Proteins expression and TUNEL assay in distal
airways of patients with ARDS and controls
ARDS Controls P
Epithelial expression of 211.5 (386.9) 131.2 (227.5) NS
SP-A (μm2/μm) × density n = 112 n = 45
Epithelial expression of 29.3 (138.1) 35.48 (56.5) NS
SP-B (μm2/μm) × density n = 136 n = 54
Epithelial expression of 132.2 (344.5) 208.9 (514.6) NS
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perimeters of the small airways for the ARDS group
and control group were 1.55 ± 0.14 and 1.45 ± 0.19 mm
(P = .273), respectively.
Table 2 and Fig. 1 show image analysis data for the
ARDS and control groups. The ARDS group showed
signiﬁcantly higher expression of IL-8 in the airway
epithelium (P = .006) and a higher number of IL-6– (P =Table 1 Clinical data and ventilatory parameters of patients
with ARDS and controls
Characteristics ARDS Controls
n 31 11
Age (y) 44 (20) 48 (25)
Sex (M/F) 16/15 7/4
PaO2/FIO2 137 (80) –
Plateau pressure (cm H2O) 28 (10) –
PEEP (cm H2O) 11 (8) –
Days of ARDS evolution 2 (8) NA
Predisposing factor for ARDS, n (%)
Pneumonia 13 (42) NA
Sepsis 11 (35)
Aspiration 2 (6)
Pancreatitis 2 (6)
Hypovolemic shock 2 (6)
Alveolar bleeding 1 (3)
Comorbidities, n (%)
Systemic arterial hypertension 9 (20) 6 (54)
Chronic hepatopathy 9 (20) 1 (20)
AIDS 8 (17) –
Diabetes mellitus 5 (11) 3 (27)
Systemic lupus erythematosus 3 (6.5) –
Pneumocystosis 3 (6.5) –
Pulmonary hypertension 1 (2.2) –
Multiple sclerosis 1 (2.2) –
Multiple myeloma 1 (2.2) –
Crohn disease 1 (2.2) –
Chagas disease 1 (2.2) 1 (9)
Schistosomosis 1 (2.2) –
Acute myeloid leukemia 1 (2.2) –
Lymphoma 1 (2.2) –
Tuberculosis 1 (2.2) –
Epilepsy – 1 (9)
Primary cause of death, n (%)
Multiorgan failure 14 (45) –
Refractory sepsis 7 (23) –
Respiratory failure 4 (13) –
Thoracic bleeding 4 (6) –
Gastrointestinal bleeding 4 (13) 1 (9)
Cardiovascular diseases – 9 (82)
Vesical bleeding – 1 (9)
Total length of hospitalization, d 15 (19) 0 (0.08)
Data are given as median (interquartile range) or n (percentage). For
each patient, plateau pressure and PEEP correspond to mean values in
the ﬁrst 48 hours. The PaO2/FIO2 corresponds to values assessed at the
time of clinical diagnosis. M indicates male; F, female; NA,
nonapplicable; PaO2/FIO2, ratio of arterial oxygen tension to the fraction
of inspired oxygen.
IL-6 (μm2/μm) × density n = 118 n = 51
Epithelial expression of 152.67 (162.2) 25.21 (59.02) .006
IL-8 (μm2/μm) × density n = 161 n = 59
Airway wall IL-6+ cell 25.5 (14.7) 13.2 (16.7) .004
density (cells*10−3/μm) n = 118 n = 51
Airway wall IL-8+ cell 12.7 ± 10.7 1.6 ± 1.8 b.001
density (cells*10−3/μm) n = 161 n = 59
Epithelial expression of 523.8 ± 457.9 779.5 ± 524.1 NS
Fas (μm2/μm) × density n = 131 n = 48
Epithelial expression of 757.7 ± 319.4 746.2 ± 276.0 NS
FasL (μm2/μm) × density n = 139 n = 39
Caspase 3 + epithelial 0.0 (0.3) 0.0 (1.0) NS
cells (cells *103/μm) n = 135 n = 46
TUNEL+ epithelial 4.5 ± 4.6 8.6 ± 5.2 .065
cells (cells * 104/μm) n = 101 n = 34
A mean of 6 airways per histologic parameter was analyzed in each
patient. NS indicates nonsigniﬁcant; n, number of analyzed airways in
each parameter per group..004) and IL-8–positive (P b .001) inﬂammatory cells in the
airway walls when compared with the control group. There
were no differences in epithelial expression of SP-A, SP-B,
IL-6, caspase 3, Fas, and FasL between the 2 groups.
Although there was no signiﬁcant difference in the number
of TUNEL-positive epithelial cells between the groups, we
observed a trend toward higher numbers of apoptotic cells in
the control group (P = .06).
3.3. Clinical correlations
The density of IL-8–positive inﬂammatory cells showed a
negative correlation with PaO2/FIO2 (r = –0.56; P = .024).
There was a signiﬁcant correlation between days of ARDS
evolution and airway epithelium Fas expression (r = 0.46;
P = .034) and a negative correlation between days of ARDS
evolution and the density of IL-6–positive cells in the airway
walls (r = –0.64; P b .001). There was no correlation
between ventilatory and histologic parameters.4. Discussion
The main ﬁnding of this study was a greater inﬂammatory
response in the small airways of patients with ARDS than in
patients who died of nonpulmonary causes. Our results also
showed that there was no difference in the apoptotic index
between the ARDS and control groups.
Fig. 1 Representative photomicrographs of small airways of the control group (A and C) and patients with ARDS (B and D) stained with
anti–IL-8 (A and B) and anti–IL-6 (C,D). There is higher expression of IL-8 in the airway epithelium and a higher number of IL-6– and IL-8–
positive inﬂammatory cells (arrows) in the airway walls in the ARDS group. L, lumen; EP, respiratory epithelium; scale bar, 50 μm.
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epithelium include providing a mechanical barrier to inhaled
particles from the environment; host defense, including the
recruitment and modulation of inﬂammatory cells; and the
direct repair of injury to the airways [24]. In airway diseases
such as chronic obstructive pulmonary disease and asthma,
the alterations in the structure and function of the respiratory
epithelium are well recognized [25]; however, little is known
about the changes in the airway epithelium in ARDS.
Experimental data show an increase in inﬂammatory
parameters in the small airways in animal models of both
ARDS and ventilator-induced lung injury [4,8]. In a
surfactant-depleted model of ALI in rats, Tsuchida et al
showed that airway epithelial injury associated with
peribronchiolar inﬂammation was generalized in the lungs,
affecting both atelectatic and nonatelectatic regions [8]. Our
results are in line with those experimental data and showed
that the small airways are involved in the overall lung
inﬂammation and cytokine production in ARDS. Interleukin
6 is one of the ﬁrst acute-phase cytokines released in sepsis
[26]; the chemotatic cytokine IL-8 is related to neutrophil
recruitment that is associated with massive lung damage in
ARDS [27]. Previous studies have shown that IL-6 serum
levels can vary during the course of ARDS, decreasing in the
ﬁrst days compared with baseline values [14]. Although this
is not a consistent ﬁnding in human ARDS [15], we observedthe same dynamics of IL-6 expression within the airway
inﬂammation cells, with higher expression of IL-6 in patients
who died within the ﬁrst days of disease evolution.
Interleukin 6 is also overexpressed in airway diseases and
has been associated with airway remodeling in asthma [28].
We have previously shown that patients who died with
ARDS present a large number of inﬂammatory cells and
remodeling of the airways [9]. We now report that these
airway inﬂammatory cells showed higher expression of IL-6
and IL-8 compared with controls and that the airway density
of IL-8+ cells was associated with ARDS severity assessed
by PaO2/FIO2 values. We suggest that airway expression of
both IL-6 and IL-8 may be involved in the mechanism of
airway injury and remodeling observed in these patients.
Although SP-A participates in innate defense and
regulates the release of surfactants by type II cells, SP-B's
main function is reducing surface tension [12,13,29].
Pulmonary surfactants in the airways are secreted by Clara
cells and involved in airway stability and prevention of ﬂuid
accumulation in the lumen, act as a barrier, and have
important immunomodulatory properties [13]. We hypoth-
esized that the expression of SP-A and SP-B would be
decreased in the airway epithelium of patients with ARDS,
which could play a role in the mechanism of distal airway
collapse. We did not ﬁnd any differences in the small airway
epithelium expressions of either SP-A or SP-B between the 2
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acute onset of ARDS have shown diminished concentrations
of SP-A and SP-B [30,31]. Our results could either indicate
that changes in airway surfactant expression do not
contribute to local airway alterations in ARDS, or if the
small airway does contribute to the decrease in the levels of
SP observed in BAL, it is likely due to the extensive damage
and sloughing of the epithelium [9]. Furthermore, although
there was no difference in the amount of airway surfactant
proteins between the groups, it is also possible that airway
surfactant function was altered in these patients.
The relative contribution of apoptosis or necrosis in
epithelial cells death in ARDS is unknown [16]. Elevated
concentrations of soluble Fas and FasL have been detected in
BAL ﬂuids from patients with ALI/ARDS [32,33]. Albertine
et al showed increased immunoexpression of Fas and FasL in
alveolar epithelial cells in patients who died with ALI/
ARDS. The rationale that the Fas/FasL system has a potential
role in airway epithelial apoptosis is based on the observation
that BAL ﬂuids obtained from patients with ARDS induced
distal lung epithelial cell apoptosis and that this apoptosis
was inhibited by blocking the Fas/FasL system [33]. In this
study, the index of airway epithelial apoptosis was assessed
with caspase 3 expression, Fas/FasL epithelial expression,
and the TUNEL assay. None of these analyses showed a
signiﬁcant difference between patients with ARDS and
controls. The results show no evidence that apoptosis is a
major mechanism of airway epithelial cell death in these
patients with ARDS patients, corroborating previous exper-
imental data that suggest that bronchiolar injury in
experimental models of ALI might be secondary to epithelial
necrosis [4,7]. Furthermore, experimental studies show that
low levels of lung injury are associated with high levels of
apoptosis, whereas increased lung injury is associated with
decreased apoptosis and increased necrosis [34-36]. Thus,
epithelial necrosis might be an important mechanism of
airway epithelial cell death in our patients due to the severity
of acute lung injury.
Some limitations of the present study should be
addressed. It is well known that pulmonary injury in
ARDS is heterogeneously distributed within the lungs;
however, the retrospective character of the study did not
allow us to systematically assess regional differences in
airway injury. Because adequate samples were not available
for all the stainings, some of the analyses did not include all
the patients, what could have decreased the strength of the
correlations. Furthermore, we did not evaluate lungs with
alterations exclusively related to mechanical ventilation.
Although there was no correlation between the ventilatory
and histologic parameters, it is not possible to exclude the
possibility that mechanical ventilation is associated to the
observed airway changes. We believe that these changes are
probably the result of both the primary pulmonary insult
leading to ARDS and a ventilator-induced injury.
In conclusion, our results showed that the distal airways
were involved in ARDS lung inﬂammation with higherexpressions of proinﬂammatory interleukins in both airway
epithelial and inﬂammatory cells compared with controls.
Our results show no evidence that apoptosis is a major
mechanism of airway epithelial cell death in ARDS.References
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